Biopeps Solutions Inc.
  • Home
  • About Us
    • Company Profile
    • Company Management
    • Scientific Advisory Board
    • Collaborative Research Partners
  • Research & Development
    • Prostate Cancer
    • BPS-001 Mechanism of Action
    • BPS-001 Pre-Clinical Data
    • BPS-001 Competitive Advantages
    • Clinical Development
  • Business Development
    • Private Investments
    • Statement of Interest Form
  • Contact Us
Biopeps Solutions Inc.

CANCER TREATMENT WITH OUR LEAD DRUG: BPS-001

Preclinical in vitro and animal studies have demonstrated BPS-001’s efficacy against a number of different prostate cancer cell lines.

WE ARE AN ELIGIBLE BUSINESS CORPORATION

Our company’s designation as an Eligible Business Corporation (EBC) has been renewed by the BC government.

Innovative therapeutic products for the treatment of cancers and other diseases

LEARN MORE
Biopep Solutions Inc.
Biopep Solutions Inc. is a privately owned development-stage biotechnology company that discovers and develops innovative therapeutic products for the treatment of cancers and other diseases. Our lead candidate drug treats prostate cancer by non-toxically and simultaneously targeting multiple cancer causing pathways. To date, Biopep Solutions has been funded privately and through government grants and is currently seeking equity to fund upcoming milestones. Investments in Biopep Solutions are RRSP eligible and qualify for a 30% BC Tax Credit. Interested investors may contact the company directly for details.
Contact Info
220-13071 Vanier Pl, Richmond, BC, V6V 2J1
+1 604-276-0020
+1 604-276-0016
info@biopeps.com
Find us on map
Copyright© 2015-2020 Biopep Solutions Inc.
  • Privacy Policy